Review of Proliferative Variables and Their Predictive Value

作者: R. Silvestrini , M. G. Daidone

DOI: 10.1007/978-3-642-84745-5_10

关键词: Disease progressionOncologyPredictive valueBreast cancerFlow cytometryEstrogen receptor positive tumorMedicineInternal medicine

摘要: The growing interest in breast cancer biology and the development of sophisticated techniques have greatly contributed to knowledge cellular molecular aspects disease progression. Markers indicative biological aggressiveness been identified [1], some these already passed from laboratory clinical application as valid prognostic indicators.

参考文章(27)
Douglas E. Merkel, C. Kent Osborne, Prognostic Factors in Breast Cancer Hematology/Oncology Clinics of North America. ,vol. 3, pp. 641- 652 ,(1989) , 10.1016/S0889-8588(18)30524-0
S M O'Reilly, R S Camplejohn, D M Barnes, R R Millis, R D Rubens, M A Richards, Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. Journal of Clinical Oncology. ,vol. 8, pp. 2040- 2046 ,(1990) , 10.1200/JCO.1990.8.12.2040
Maria Grazia Daidone, Rosella Silvestrini, Antonia D'Errico, Giovanni Di Fronzo, Elvira Benini, Antonio M. Mancini, Spiridione Garbisa, Lance A. Liotta, Walter F. Grigioni, Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. International Journal of Cancer. ,vol. 48, pp. 529- 532 ,(1991) , 10.1002/IJC.2910480409
W. Weikel, T. Beck, M. Mitze, P. G. Knapstein, Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast Cancer Research and Treatment. ,vol. 18, pp. 149- 154 ,(1991) , 10.1007/BF01990030
N Bouzubar, KJ Walker, K Griffiths, IO Ellis, CW Elston, JFR Robertson, RW Blamey, RI Nicholson, Ki67 immunostaining in primary breast cancer: pathological and clinical associations. British Journal of Cancer. ,vol. 59, pp. 943- 947 ,(1989) , 10.1038/BJC.1989.200
J Gerdes, R J Lelle, H Pickartz, W Heidenreich, R Schwarting, L Kurtsiefer, G Stauch, H Stein, Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. Journal of Clinical Pathology. ,vol. 39, pp. 977- 980 ,(1986) , 10.1136/JCP.39.9.977
Aysegul A. Sahin, Jae Y. Ro, Adel K. El-Naggar, Nelson G. Ordonez, Alberto G. Ayala, Jungsil Ro, Gabriel N. Hortobagyi, Mark B. Blick, Herbert A. Fritsche, Terry L. Smith, Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer. ,vol. 68, pp. 549- 557 ,(1991) , 10.1002/1097-0142(19910801)68:3<549::AID-CNCR2820680318>3.0.CO;2-J
Giampietro Gasparini, Sandro Dal Fior, Franco Pozza, Pierantonio Bevilacqua, Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma Breast Cancer Research and Treatment. ,vol. 14, pp. 329- 336 ,(1989) , 10.1007/BF01806305
Maurice Tubiana, Marie Héléne Pejovic, Serge Koscielny, Nicole Chavaudra, Edmond Malaise, Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. International Journal of Cancer. ,vol. 44, pp. 17- 22 ,(1989) , 10.1002/IJC.2910440104